Výsledky vyhledávání - Michelle Knowles
- Zobrazuji výsledky 1 - 3 z 3
-
1
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma Autor Lipika Goyal, Hui Zheng, Matthew B. Yurgelun, Thomas A. Abrams, Jill N. Allen, James M. Cleary, Michelle Knowles, Eileen Regan, Amanda Reardon, Anna Khachatryan, Rakesh K. Jain, Valentina Nardi, Darrell R. Borger, Dan G. Duda, Andrew X. Zhu
Vydáno 2017Artigo -
2
Efficacy, Safety, Pharmacokinetics, and Biomarkers of Cediranib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study Autor Andrew X. Zhu, Marek Ancukiewicz, Jeffrey G. Supko, Dushyant V. Sahani, Lawrence S. Blaszkowsky, Jeffrey A. Meyerhardt, Thomas A. Abrams, Nadine J. McCleary, Pankaj Bhargava, Alona Muzikansky, Susan Sheehan, Eileen Regan, Eamala Vasudev, Michelle Knowles, Charles S. Fuchs, David P. Ryan, Rakesh K. Jain, Dan G. Duda
Vydáno 2013Artigo -
3
A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma Autor Lipika Goyal, Hui Zheng, Thomas A. Abrams, Rebecca A. Miksad, Andrea J. Bullock, Jill N. Allen, Matthew B. Yurgelun, Jeffrey W. Clark, Avinash Kambadakone, Alona Muzikansky, Michelle Knowles, Aralee Galway, Anthony J. Afflitto, Caroline F. Dinicola, Eileen Regan, Tai Hato, Émilie Mamessier, Kohei Shigeta, Rakesh K. Jain, Dan G. Duda, Andrew X. Zhu
Vydáno 2018Artigo
Vyhledávací nástroje:
Související témata
Clinical endpoint
Clinical trial
Gastroenterology
Internal medicine
Medicine
Oncology
Cancer
Hepatocellular carcinoma
Sorafenib
Biochemistry
Biomarker
Cabozantinib
Chemistry
Colorectal cancer
Environmental health
FOLFOX
Gemcitabine
Liver function
Oxaliplatin
Pharmacokinetics
Pharmacology
Phases of clinical research
Population
Surrogate endpoint
VEGF receptors
Vascular endothelial growth factor